TARS
#1869
Tarsus Pharmaceuticals, Inc. - Common Stock
56.7 7 USD
+0.01%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+1.18%
Variación mensual
-8.63%
Variación en los últimos 6 meses
-22.88%
Cambio anual
-14.06%
Cierres anteriores
56.1 1
Open
55.5 5
Mínimo
55.5 5
High
56.7 7
Volumen
615
Financials
- Market Capitalization 2.44 B
- Employee 370
- Founded 2016
- CEO N/A
- Website www.tarsusrx.com
- Headquarter Delaware, United States
- FIGI BBG00RB9BNQ7
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-63.2
Relación precio/flujo de caja
5.56
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1850 |  TRVI Trevi Therapeutics, Inc. - Common Stock | 18.15 USD | +1.34% | -2.37% | +23.72% | +164.58% | 2.58 B USD | ||
| 1867 |  NRIX Nurix Therapeutics, Inc. - Common stock | 23.74 USD | +3.31% | -0.50% | +40.22% | +111.78% | 2.46 B USD | ||
| 1871 |  SLS SELLAS Life Sciences Group, Inc. - Common Stock | 12.79 USD | -4.48% | -7.05% | +68.29% | +566.15% | 2.38 B USD | ||
| 1875 |  VCEL Vericel Corporation - Common Stock | 47.23 USD | +2.47% | +0.79% | +22.93% | +29.93% | 2.41 B USD |